Timing clarification: Brown & Brown is scheduled to release earnings after the market closes today, Monday, July 27, 2026. Management’s earnings call is tomorrow, Tuesday, July 28, at 8:00 a.m. EDT.
Brown & Brown enters Q2 with a fairly clear debate:
The stock closed at $67.68 on July 24, up about 7% from its post-Q1 close but trailing the gains of several large brokerage peers over the same period. That suggests expectations are not especially demanding, but the market will still require credible signs that organic growth has bottomed.
| Metric | 2026 Q1 result |
|---|---|
| Revenue | $1.90 billion |
| Reported revenue growth | 35.4% |
| Organic revenue growth, ex-contingents | 0.0% |
| Organic growth, including contingents | 2.2% |
| Adjusted EBITDAC margin | 38.5% |
| Adjusted EPS | $1.39 |
| Adjusted EPS growth | 7.8% |
| Operating cash flow | $262 million |
Reported growth was driven primarily by Accession, which contributed approximately $445 million of Q1 revenue. The underlying business was held back by catastrophe-property pricing, prior-year flood claims revenue, changes in a pharmacy consulting revenue model and disruption related to employee departures.
This is the central issue.
Management said after Q1 that it expected modest sequential organic improvement in every quarter of 2026. That sets a relatively low but important hurdle: consolidated organic growth excluding contingents should move above Q1’s flat result.
The segment expectations are more informative:
A result modestly above zero may satisfy the literal guidance, but investors will want to see underlying indicators—new business, retention and exposure growth—that support more meaningful improvement later in the year.
BRO’s Specialty Distribution business has meaningful catastrophe-property exposure, making it more sensitive than some peers to falling property rates.
In Q1, management reported:
The industry read-through has not improved. Marsh recently reported:
That backdrop makes management’s prior expectation of roughly flat Specialty Distribution organic growth a meaningful test. A result near flat would imply that policy growth, new business and non-property lines are largely offsetting substantial rate pressure. A materially negative figure would suggest the pricing drag is overwhelming those offsets.
Investors should also listen for whether management believes June renewals marked a trough. At the Q1 call, it had not yet seen evidence that the decline was stabilizing.
Contingent commissions are unusually important to the BRO story.
In Q1:
Management argues that this is structurally linked to its business model: lower property rates often follow favorable insurer underwriting results, which can generate higher profit-based contingent commissions.
The company now expects total contingents to increase in 2026, reversing its earlier expectation that Specialty Distribution contingents would decline by approximately $15 million.
However, Q1 included:
Therefore, another large year-over-year increase would be positive, but investors should distinguish recurring underwriting profitability from timing benefits and true-ups.
Q2 2025 revenue was $1.285 billion and did not include Accession operating results. With Accession now fully consolidated, BRO should post another quarter of reported revenue growth well above 30%.
That growth rate will not be the key investment signal. More important questions are:
Management previously said Accession’s revenue and profit are roughly balanced between the first and second halves, with the third quarter carrying more weight than the fourth. Q2 therefore may not be the strongest Accession quarter, but there should be no material deterioration in the full-year outlook.
Accession’s 180 Intermediaries operations should begin entering organic calculations in the second half. Because 180 has more casualty exposure and relatively little catastrophe property, management expects it to improve Specialty Distribution’s growth profile. Commentary on that transition could matter more than Q2’s acquired revenue contribution.
One pharmacy consulting operation is shifting from a volume-based arrangement to a per-employee-per-month model. Management expects this to reduce Retail organic growth by 50–100 basis points for several quarters, before growth resumes toward year-end.
A weak Retail result will be easier to look through if this is the primary cause and the transition remains on schedule. It will be more concerning if net-new business or retention also deteriorates.
BRO is combining the local sales approach of legacy Brown & Brown with the more regional model used by Risk Strategies. Management said producer activity was improving and expressed optimism about the second half.
Investors should look for tangible evidence:
At the end of Q1, customers representing approximately $31 million of annual revenue had moved to the competing start-up, up from $23 million previously. The Q1 revenue impact was approximately $10 million.
BRO excludes the identified impact from its organic-growth calculation. That makes the reconciliation important:
The cleanest outcome would be a limited increase in lost revenue, continued hiring and no change to the expected Retail growth trajectory.
Q2 2025’s adjusted EBITDAC margin was 36.7%. Q1 2026 was unusually strong at 38.5%, helped by high contingent commissions and favorable seasonality in the legacy business.
For Q2, the key question is not whether margin matches Q1. Rather, investors should evaluate whether BRO can sustain a margin in the mid-to-upper 30% range despite:
Positive offsets include contingents, acquisition synergies, disciplined expense management and the temporary compensation benefit associated with employee departures.
A roughly stable margin relative to the prior-year quarter would be a solid result. Material contraction without a corresponding acceleration in investment or growth would be disappointing.
Adjusted EPS growth also deserves attention because the Accession transaction increased both debt and the diluted share count. Q1 adjusted EPS grew 7.8% despite approximately 52 million additional weighted-average shares. Another high-single-digit increase would indicate that operating profit growth is successfully absorbing the transaction’s financing and dilution.
At March 31, BRO had:
BRO also repurchased approximately $350 million of stock over the six months preceding the Q1 call, reducing its share count by about five million shares.
The balance sheet is not the main near-term concern, but investors should expect an update on:
With the large Accession transaction complete, a visible reduction in leverage would strengthen the story. Aggressive buybacks or M&A without corresponding deleveraging could receive a more mixed reaction.
This would probably be viewed as evidence that the business is managing through the soft property market, but not yet producing a decisive growth reacceleration.
The headline numbers should look strong because of Accession, but Q2 is fundamentally a test of whether BRO’s underlying growth has bottomed.
The most constructive result would combine modest sequential improvement in organic growth, approximately flat Specialty Distribution performance despite severe property-rate pressure, resilient margins and unchanged confidence in the second-half acceleration. Strong contingents can support earnings, but they will not fully resolve the debate unless Retail new business and Accession-related growth also begin to improve.
For this report, organic growth by segment, the quality of contingents, Accession execution and the updated customer-loss figure matter more than the reported revenue growth rate.